Expand ATAI Menu
ATAI MENU

ATAI Latest Press Releases

-- January 8, 2026 --

AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference Globe Newswire 7:00 AM

-- December 30, 2025 --

AtaiBeckley Completes Redomiciliation to the United States Globe Newswire 7:13 PM

-- December 23, 2025 --

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) Globe Newswire 7:00 AM

-- December 11, 2025 --

AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio Globe Newswire 7:00 AM

-- November 19, 2025 --

Enhanced Fortifies Executive Leadership Team & Board of Directors PRNewswire 7:33 PM

-- November 13, 2025 --

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London Globe Newswire 9:00 AM

-- November 12, 2025 --

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 7:00 AM

-- November 10, 2025 --

AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression Globe Newswire 7:00 AM

-- November 5, 2025 --

atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies Globe Newswire 7:00 AM

-- October 20, 2025 --

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares Globe Newswire 5:29 PM

-- October 16, 2025 --

atai Life Sciences Announces Pricing of Public Offering of Common Shares Globe Newswire 10:31 PM
atai Life Sciences Announces Proposed Public Offering of Common Shares Globe Newswire 4:12 PM
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression Globe Newswire 4:10 PM

-- September 23, 2025 --

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression Globe Newswire 7:00 AM

-- September 18, 2025 --

atai Life Sciences Awarded Grant from the National Institutes of Health Globe Newswire 8:00 AM

-- August 28, 2025 --

atai Life Sciences to Participate in September Investor Conferences Globe Newswire 4:05 PM

-- August 14, 2025 --

atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes